Theravance Biopharma Inc (TBPH)

May 22, 2026

Theravance Biopharma (TBPH) CEO has shares withheld to cover RSU taxes - Stock Titan

May 22, 2026

May 22, 2026

Theravance Biopharma (NASDAQ: TBPH) CFO has 8,670 shares withheld for RSU taxes - Stock Titan

May 22, 2026

May 22, 2026

Theravance Biopharma (TBPH) SVP has shares withheld for RSU taxes - Stock Titan

May 22, 2026

May 22, 2026

Theravance Biopharma (TBPH) SVP has 8,829 shares withheld for RSU tax - Stock Titan

May 22, 2026

May 22, 2026

Theravance Biopharma (TBPH) SVP uses 5,678 shares to cover tax bill - Stock Titan

May 22, 2026

May 18, 2026

Theravance Biopharma (TBPH) Q4 earnings and revenues lag estimates - MSN

May 18, 2026

May 15, 2026

Behavioral Patterns of TBPH and Institutional Flows - Stock Traders Daily

May 15, 2026

May 13, 2026

Are Options Traders Betting on a Big Move in Theravance Biopharma Stock? - TradingView

May 13, 2026

May 11, 2026

BTIG Maintains Theravance Biopharma (TBPH) Buy Recommendation - MSN

May 11, 2026

May 09, 2026

Here's why Theravance Biopharma (TBPH) is a strong momentum stock - MSN

May 09, 2026

May 08, 2026

TBPH Q1 Earnings Beat Amid Strategic Restructuring & Pipeline Hurdle - sharewise.com

May 08, 2026

May 08, 2026

BTIG Maintains Theravance Biopharma(TBPH.US) With Buy Rating, Maintains Target Price $21 - Moomoo

May 08, 2026

May 08, 2026

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Strong Revenue Growth and Strategic Collaborations Point to Promising Future - DirectorsTalk Interviews

May 08, 2026

May 07, 2026

Theravance Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 07, 2026

May 07, 2026

Earnings Flash (TBPH) Theravance Biopharma, Inc. Reports Q1 Revenue $17.7M, vs. FactSet Est of $17.8M - marketscreener.com

May 07, 2026

May 07, 2026

Theravance Biopharma Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 07, 2026

May 07, 2026

Theravance Biopharma (NASDAQ: TBPH) slashes R&D after ampreloxetine trial miss - Stock Titan

May 07, 2026

May 07, 2026

Theravance Biopharma reports Q1 2026 revenue $17.7M, narrows net loss to $4.9M - TradingView

May 07, 2026

May 07, 2026

Ireland's Theravance Biopharma Q1 revenue beats estimates on YUPELRI growth - TradingView

May 07, 2026

May 07, 2026

Theravance Bio: Q1 Earnings Snapshot - KTVB

May 07, 2026

May 07, 2026

Theravance (NASDAQ: TBPH) targets $60–70M cash flow after major restructuring - Stock Titan

May 07, 2026

May 07, 2026

Theravance Biopharma: Confident Will Achieve $100 Million Milestone Payment Associated With 2026 Trelegy Net Sales >TBPH - Moomoo

May 07, 2026

May 07, 2026

Theravance Biopharma, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update - ChartMill

May 07, 2026

May 07, 2026

Here's Why Theravance Biopharma (TBPH) is a Strong Momentum Stock - Yahoo Finance

May 07, 2026

May 06, 2026

MSN Money - MSN

May 06, 2026

May 04, 2026

(TBPH) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

May 04, 2026

May 04, 2026

Theravance's Q4 earnings and revenues miss estimates - MSN

May 04, 2026

May 03, 2026

Theravance stock declines around 17% in three months: Here's why - MSN

May 03, 2026

May 02, 2026

Theravance Biopharma (NASDAQ:TBPH) Lowered to "Buy" Rating by Wall Street Zen - MarketBeat

May 02, 2026

Apr 30, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc.TBPH - PR Newswire

Apr 30, 2026

Apr 28, 2026

Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc.TBPH - FinancialContent

Apr 28, 2026

Apr 28, 2026

Theravance Biopharma (NASDAQ: TBPH) sets 2026 AGM votes on board, pay, auditor - Stock Titan

Apr 28, 2026

Apr 28, 2026

A Pivotal Quarter for Theravance Biopharma (TBPH): Milestone Cash Influx and a Transition to Pure Commercial Play - AlphaStreet

Apr 28, 2026